Biophosphonates in therapy for osteoporosis
https://doi.org/10.14341/probl200854351-54
Abstract
Osteoporosis (OP) is a progressive systemic disease of the skeleton, characterized by a decrease in density and a violation of bone microarchitectonics, with a constant increase in bone fragility and the risk of fractures. The relevance of the problem of OP in modern medicine is due primarily to the social and economic consequences of fractures. Moreover, the problem of OP in the future will become even more serious and global, since in modern society there is an increase in life expectancy, the general aging of the population, and already in 2002 the number of residents over 50 years old doubled.
About the Authors
A. M. MkrtumyanMoscow State Medical and Dental University
Russian Federation
Ye. V. Biryukova
Moscow State Medical and Dental University
Russian Federation
References
1. Риггз Б. Л., Аклтоп III Л. Д. Остсопороз. Этиология, диагностика, лечение. - М., 2000.
2. Шварц Г. Я. Фармакотерапия остеопороза. - М., 2002.
3. Amin S., Felson D. P. // Rheum. Dis. Clin. N. Am. - 2001. -Vol. 27, N 1. - P. 19-47.
4. Boivin G. Y, Chavassieux P. М., Santora A. С. et al. // Bone. - 2000. - Vol. 27. N 5. - P. 687-694.
5. Bone H. C., Hosking D., Devogelaer J. P. et al. // N. Engl. J. Med. - 2004. - Vol. 350, N 12. - P. 1189-1199.
6. Chesnut III С Н., Shag A., Christiansen С et al. // J. Bone Miner. Res. - 2004. - Vol. 19, N 8. - P. 1241-1249.
7. Davidson M. R. // J. Midwifery Womcns Hkh. - 2003. - Vol. 4S. - P. 39-52.
8. Eastell R. // N. Engl. J. Med. - 1998. - Vol. 338, N 11. -P. 736-746.
9. Emkey R., Koltun W., Beusterien K. et al. // Curr. Med. Res. Opin. - 2005. - Vol. 21. N 12. - P. 1895-1903.
10. Ensrud K. E., Barrett-Connor E. L., Schwartz A. et al. // J. Bone Miner. Res. - 2004. - Vol. 19, N 8. - P. 1259-1269.
11. Heaney R. P. // Clin. Med. Res. - 2003. - Vol. 1, N 2. -P. 93-99.
12. Hodsman В., Hапку D. A., Josse R. // J. Bone Miner. Res. - 2004. - Vol. 19, N 8. - P. 1241-1249.
13. Hughes D. E., Wright K. R., Uy H. L. et al. // J. Bone Miner. Res. - 1995. - Vol. 10. - P. 1478-1487.
14. Mashiba Т., Turner С. H., Hirano Т. et al. // Bone. - 2001. -Vol.28, N5.-P. 524-531.
15. Meilstrom D. D., Sorensen O. H, Goemaere S. et al. // Calcif. Tiss. Int. - 2004. - Vol. 75, N 6. - P. 462-468.
16. Miller P. D., McClung M., Macovei I. et al. // J. Bone Miner. Res. - 2005. - Vol. 20. - P. 1315-1322.
17. Atonier-Faugere M. C, Geng Z, Paschalis E. P. et al. // J. Bone Miner. Res. - 1999. - Vol. 14. - P. 1768-1778.
18. Nguyen T. V., Center J. R., Eisman J. A. // Med. J. Aust. - 2004. - Vol. 180, N 5. - P. 18-22.
19. Papapoulos S. E. // Int. J. Clin. Pharmacol. - 2003. - Vol. 57.-P. 417-422.
20. Pecherstoifer M., Steinhauer E. U., Rizzoli R. et al. // Support Care Cancer. - 2003. - Vol. 11, N 8. - P. 539-547.
21. Pyon E. Y. // Clin. Ther. - 2006. - Vol. 28, N 4. - P. 475-490.
22. Recker R., Ensrud K., Diem S. et al. // J. Bone Miner. Res. - 2004. - Vol. 19. - P. S45.
23. Rodan G., Reszka A., Golub E., Rizzoli R. /J Curr. Med. Res. Opin. - 2004. - Vol. 20, N 8. - P. 1291-1300.
24. Rogers M. J. // Curr. Pham. Des. - 2003. - Vol. 9. -P. 2643-2658.
Review
For citations:
Mkrtumyan A.M., Biryukova Ye.V. Biophosphonates in therapy for osteoporosis. Problems of Endocrinology. 2008;54(3):51-54. (In Russ.) https://doi.org/10.14341/probl200854351-54
Views:
20129
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
